Silvia Esfahani-Darb

Spandau, BE 13589, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.

LRP1B-a prognostic marker in tubo-ovarian high-grade serous carcinoma.

Journal: Human pathology

Published: July 30, 2023

Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.

Increased expression of IDO1 is associated with improved survival and increased number of TILs in patients with high-grade serous ovarian cancer.

Journal: Neoplasia (New York, N.Y.)

Published: June 22, 2023

AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.

AHRR and SFRP2 in primary versus recurrent high-grade serous ovarian carcinoma and their prognostic implication.

Journal: British journal of cancer

Published: December 04, 2022

Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling".

Correction to "Integration of Metabolomics and Expression of Glycerol-3-phosphate Acyltransferase (GPAM) in Breast Cancer─Link to Patient Survival, Hormone Receptor Status, and Metabolic Profiling".

Journal: Journal of proteome research

Published: June 01, 2022

Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer.

Polycomb Protein BMI-1 as a Potential Therapeutic Target in Mucinous Ovarian Cancer.

Journal: Anticancer research

Published: January 26, 2022

Disseminated pulmonary AL amyloidosis associated with lymphoplasmacytic lymphoma.

Disseminated pulmonary AL amyloidosis associated with lymphoplasmacytic lymphoma.

Journal: EJHaem

Published: March 05, 2021

Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.

Classification of Molecular Subtypes of High-Grade Serous Ovarian Cancer by MALDI-Imaging.

Journal: Cancers

Published: February 22, 2021

Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis.

Impact of clinical factors and surgical outcome on long-term survival in high-grade serous ovarian cancer: a multicenter analysis.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 31, 2020

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging.

Discovery of Prognostic Markers for Early-Stage High-Grade Serous Ovarian Cancer by Maldi-Imaging.

Journal: Cancers

Published: June 23, 2020

Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.

Stable expansion of high-grade serous ovarian cancer organoids requires a low-Wnt environment.

Journal: The EMBO journal

Published: November 14, 2019

PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.

PIK3CA H1047R Mutation Associated with a Lower Pathological Complete Response Rate in Triple-Negative Breast Cancer Patients Treated with Anthracycline-Taxane-Based Neoadjuvant Chemotherapy.

Journal: Cancer research and treatment

Published: August 27, 2019

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer.

Discovery and Validation of Novel Biomarkers for Detection of Epithelial Ovarian Cancer.

Journal: Cells

Published: May 08, 2019

Showing 1-12 of 83

Last Updated: 09/26/2026